微RNAs:在阿尔茨海默病的发病,诊断和治疗方面开创性的调节者
Yao-Bo Li1, Qiang Fu2, Mei Guo3
1Center on Translational Neuroscience, College of Life and Environmental Sciences, Minzu University of China, Beijing, China.
Translational psychiatry
|September 10, 2024
概括
微RNAs (MiRNAs) 在阿尔茨海默病 (AD) 进展中发挥着关键作用. 了解这些小RNA为这种神经退行性疾病提供了新的诊断和治疗点.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
背景情况:
- 阿尔茨海默病 (AD) 是老年人认知能力下降的主要原因.
- 阿尔茨海默病的发病过程涉及复杂的分子途径,包括蛋白质聚合和神经炎症.
- 微RNAs (MiRNAs) 正在成为神经退行性疾病的关键调节者.
研究的目的:
- 审查微RNAs (MiRNAs) 在阿尔茨海默氏症 (AD) 病原发生中的特定作用.
- 探索MiRNAs如何影响AD的关键病理标志.
- 突出MiRNAs作为AD的诊断标记物和治疗点的潜力.
主要方法:
- 关于MiRNAs和AD的最近研究的文献综述.
- 对MiRNA参与β-粉样蛋白 (Aβ) 和病理学的分析.
- 检查米RNA对神经炎症,氧化应激和APOE4表达的影响.
主要成果:
- 特定的MiRNAs参与调节Aβ积累和陶蛋白聚合.
- 在AD模型中,MiRNAs影响线粒体功能和神经炎症反应.
- 密RNA失调与APOE4基因的表达有关,APOE4基因是AD的风险因素.
结论:
- 微RNA是驱动阿尔茨海默病的分子机制的组成部分.
- 针对特定的MiRNAs是对AD诊断和治疗的有希望的策略.
- 对MiRNA功能的进一步研究可以阐明AD病理,并指导治疗的发展.
相关概念视频
Alzheimer's Disease: Overview
452
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
452
Alzheimer's Disease: Treatment
170
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
170
siRNA - Small Interfering RNAs
16.6K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.6K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Neural Regulation
39.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K


